Insider · CIK 0001620548

Pena Luis C.

Reports to the SEC for 2 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001620548

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	EVMNEvommune, Inc.A Award	Director, President & CEO	AAward	+1,115 sh	$7.02	+$7,827.3	631,573
2026-06-22	EVMNEvommune, Inc.S Sale	Director, President & CEO	SSale	−7,438 sh	$22.71	−$169K	630,458
2026-06-01	EVMNEvommune, Inc.S Sale	Director, President & CEO	SSale	−16.8K sh	$22.74	−$382K	637,896
2026-04-16	EVMNEvommune, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+291K sh	—	—	291,420
2025-12-09	EVMNEvommune, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−28.1K sh	$17.84	−$502K	654,683
2025-11-07	EVMNEvommune, Inc.C Conversion	Director, President & CEO	CConversion	+24.2K sh	—	—	682,821
2025-11-07	EVMNEvommune, Inc. · Series Seed Preferred StockC Conversion	Director, President & CEO	CConversion	−206K sh	—	—	0
2025-11-05	EVMNEvommune, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+797K sh	—	—	796,841
2020-02-20	Dermira, Inc.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−18.2K sh	$18.75	−$342K	0
2020-02-20	Dermira, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−88.3K sh	—	—	0
2020-02-20	Dermira, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−32.5K sh	—	—	0
2020-02-20	Dermira, Inc.Employee Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−71.4K sh	—	—	0
2020-02-20	Dermira, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−17.1K sh	—	—	0
2020-02-20	Dermira, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−50.2K sh	—	—	0
2020-02-20	Dermira, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−60K sh	—	—	0
2020-02-20	Dermira, Inc.Employee Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−10K sh	—	—	0
2020-02-20	Dermira, Inc.Employee Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−48.8K sh	—	—	0
2020-02-20	Dermira, Inc.Employee Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−63.8K sh	—	—	0
2020-02-20	Dermira, Inc.Employee Stock Options (Right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−65K sh	—	—	0
2020-02-20	Dermira, Inc.Restricted Stock UnitD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−2,437 sh	—	—	0
2020-02-20	Dermira, Inc.Restricted Stock UnitD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−6,378 sh	—	—	0
2020-02-20	Dermira, Inc.Restricted Stock UnitD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−25K sh	—	—	0
2020-02-20	Dermira, Inc.Restricted Stock UnitD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−15K sh	—	—	0
2019-08-19	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+3,576 sh	$0.99	+$3,525.936	40,628
2019-08-19	Dermira, Inc.S Sale	Chief Development Officer	SSale	−23.4K sh	$8.54	−$200K	17,209
2019-08-19	Dermira, Inc.Employee Stock Options (Right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−3,576 sh	—	—	88,251
2019-08-15	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+3,189 sh	—	—	35,893
2019-08-15	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+3,000 sh	—	—	38,893
2019-08-15	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+2,438 sh	—	—	41,331
2019-08-15	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−1,209 sh	$7.91	−$9,563.19	40,122
2019-08-15	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−1,488 sh	$7.91	−$11.8K	38,634
2019-08-15	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−1,582 sh	$7.91	−$12.5K	37,052
2019-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−2,438 sh	—	—	2,437
2019-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−3,189 sh	—	—	6,378
2019-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−3,000 sh	—	—	0
2019-05-17	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+25K sh	—	—	41,349
2019-05-17	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−8,645 sh	$10.50	−$90.8K	32,704
2019-05-17	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−25K sh	—	—	25,000
2019-02-12	Dermira, Inc.Employee Stock Options (Right to buy)A Award	Chief Development Officer	AAward	+65K sh	—	—	65,000
2019-02-12	Dermira, Inc.Restricted Stock UnitA Award	Chief Development Officer	AAward	+15K sh	—	—	15,000
2018-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+50K sh	—	—	50,000
2018-08-15	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,063 sh	—	—	11,610
2018-08-15	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+2,437 sh	—	—	14,047
2018-08-15	Dermira, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+3,000 sh	—	—	17,047
2018-08-15	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−368 sh	$9.58	−$3,525.44	16,679
2018-08-15	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−843 sh	$9.58	−$8,075.94	15,836
2018-08-15	Dermira, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−1,038 sh	$9.58	−$9,944.04	14,798
2018-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,063 sh	—	—	9,567
2018-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−2,437 sh	—	—	4,875
2018-08-15	Dermira, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−3,000 sh	—	—	3,000

Recent filings

Accepted (ET)
Oct 154
Pena Luis C.0001620548-26-000009
SEC(opens sec.gov)
Jun 244
Pena Luis C.0001620548-26-000007
SEC(opens sec.gov)
Jun 34
Pena Luis C.0001620548-26-000005
SEC(opens sec.gov)
Apr 174
Pena Luis C.0001620548-26-000003
SEC(opens sec.gov)
Dec 114
Pena Luis C.0001620548-25-000011
SEC(opens sec.gov)
Nov 124
Pena Luis C.0001620548-25-000009
SEC(opens sec.gov)
Nov 74
Pena Luis C.0001620548-25-000007
SEC(opens sec.gov)
Feb 244
Pena Luis C.0001562180-20-001613
SEC(opens sec.gov)

Companies

Address

C/O EVOMMUNE, INC. 1891 PAGE MILL ROAD

PALO ALTO, CA, 94304